Taken together, these results demonstrate the efficacy of resveratrol in overcoming docetaxel-induced HER-2 activation and its downstream survival signal Akt, which is pivotal in resveratrol-induced chemosensitization of breast cancer cells to docetaxel. Here, ERBB2 is linked to breast cancer.